NUT Midline Carcinoma Treatment Market Growth Driven by Advances in Rare Cancer Therapies
Rare cancers represent one of the most challenging areas of oncology due to limited patient populations, complex diagnosis, and fewer established treatment pathways. Among these rare malignancies, NUT carcinoma is an aggressive cancer type associated with genetic changes involving the NUTM1 gene. Increasing research efforts, advancements in molecular diagnostics, and the development of targeted...
0 Комментарии 0 Поделились